Fig 1.
Interactions between Zygosaccharomyces sp. SDBC30G1 and Candida sp. SDCP2 VOCs.
(A) Diagram illustrating the procedure where the cell-free supernatant of Candida sp. SDCP2 was transferred to a Petri dish and, on top of it, a fresh inoculated Zygosaccharomyces sp. SDBC30G1 was placed. (B) Culture of Zygosaccharomyces sp. SDBC30G1 after the contact with VOCs from Candida sp. SDCP2. (C) Culture of Zygosaccharomyces sp. SDBC30G1 after exposure to VOCs from unconditioned culture medium.
Fig 2.
The effects of Monascus ruber SDCP1 secondary metabolites on Candida sp. SDCP2 and Zygosaccharomyces sp. SDBC30G1 growth.
(A) Monascus ruber SDCP1 monoculture. (B) Monascus ruber SDCP1 cultured with Candida sp. SDPC2. (C) Candida sp. SDPC2 monoculture. (D) Candida sp. SDPC2 cells in monoculture (left) and co-culture with Monascus ruber SDCP1 (right) in liquid medium (scale 10 μm). (E) Lovastatin (3.125 μM, 6.25 μM and 12.5 μM) inhibitory effects on Zygosaccharomyces sp. SDBC30G1 growth in liquid medium.
Fig 3.
Scaptotrigona depilis-associated fungal community interactions.
Depiction representing the stimulator that represents stimulatory (blue) and inhibitory (red) effects mediated by small molecules produced by the tripartite fungal community isolated from Scaptotrigona depilis brood cells.